Publication Cover
Baylor University Medical Center Proceedings
The peer-reviewed journal of Baylor Scott & White Health
Volume 31, 2018 - Issue 3
160
Views
15
CrossRef citations to date
0
Altmetric
Review Articles

Chronic peritoneal indwelling catheters for the management of malignant and nonmalignant ascites

, BS, , MD & , MD
Pages 297-302 | Received 12 Feb 2018, Accepted 02 Apr 2018, Published online: 01 Jun 2018

  • Siqueira F, Kelly T, Saab S. Refractory ascites: pathogenesis, clinical impact, and management. Gastroenterol Hepatol. 2009;5:647–656.
  • Sangisetty SL, Miner TJ. Malignant ascites: a review of prognostic factors, pathophysiology and therapeutic measures. World J Gastrointest Surg. 2012;4:87–95. doi:10.4240/wjgs.v4.i4.87. PMID: 22590662.
  • Khan J, Pikkarainen P, Karvonen AL, et al. Ascites: aetiology, mortality and the prevalence of spontaneous bacterial peritonitis. Scand J Gastroenterol. 2009;44:970–974. doi:10.1080/00365520902964739. PMID: 19440927.
  • Burleigh J, Mehta Z, Ellison N. Tunneled indwelling catheters for malignant ascites #308. J Palliat Med. 2016;19:671–672. doi:10.1089/jpm.2016.0025. PMID: 27223889.
  • Kathpalia P, Bhatia A, Robertazzi S, et al. Indwelling peritoneal catheters in patients with cirrhosis and refractory ascites. Intern Med J. 2015;45:1026–1031. doi:10.1111/imj.12843. PMID: 26122531.
  • Solbach P, Höner Zu Siederdissen C, Taubert R, et al. Home-based drainage of refractory ascites by a permanent-tunneled peritoneal catheter can safely replace large-volume paracentesis. Eur J Gastroenterol Hepatol. 2017;29:539–546. doi:10.1097/MEG.0000000000000837. PMID: 28350743.
  • Lungren MP, Kim CY, Stewart JK, Smith TP, Miller MJ. Tunneled peritoneal drainage catheter placement for refractory ascites: single-center experience in 188 patients. J Vasc Interv Radiol. 2013;24:1303–1308. doi:10.1016/j.jvir.2013.05.042. PMID: 23876552.
  • Hicks AM, Chou J, Capanu M, Lowery MA, Yu KH, O'Reilly EM. Pancreas adenocarcinoma: ascites, clinical manifestations, and management implications. Clin Colorectal Cancer. 2016;15:360–368. doi:10.1016/j.clcc.2016.04.014. PMID: 27262896.
  • Rosenberg S, Courtney A, Nemcek AA, Omary RA. Comparison of percutaneous management techniques for recurrent malignant ascites. J Vasc Interv Radiol. 2004;15:1129–1131. doi:10.1097/01.RVI.0000136828.42612.B4. PMID: 15466800.
  • Maleux G, Indesteege I, Laenen A, Verslype C, Vergote I, Prenen H. Tenckhoff tunneled peritoneal catheter placement in the palliative treatment of malignant ascites: technical results and overall clinical outcome. Radiol Oncol. 2016;50:197–203. PMID: 27247552.
  • Gu X, Zhang Y, Cheng M, Liu M, Zhang Z, Cheng W. Management of non-ovarian cancer malignant ascites through indwelling catheter drainage. BMC Palliat Care. 2016;15:44. doi:10.1186/s12904-016-0116-5. PMID: 27103467.
  • Mercadante S, Intravaia G, Ferrera P, Villari P, David F. Peritoneal catheter for continuous drainage of ascites in advanced cancer patients. Support Care Cancer. 2008;16:975–978. doi:10.1007/s00520-008-0453-x. PMID: 18449571.
  • Narayanan G, Pezeshkmehr A, Venkat S, Guerrero G, Barbery K. Safety and efficacy of the PleurX catheter for the treatment of malignant ascites. J Palliat Med. 2014;17:906–912. doi:10.1089/jpm.2013.0427. PMID: 24885753.
  • Courtney A, Nemcek AA, Rosenberg S, Tutton S, Darcy M, Gordon G. Prospective evaluation of the PleurX catheter when used to treat recurrent ascites associated with malignancy. J Vasc Interv Radiol. 2008;19:1723–1731. doi:10.1016/j.jvir.2008.09.002. PMID: 18951041.
  • Tapping CR, Ling L, Razack A. PleurX drain use in the management of malignant ascites: safety, complications, long-term patency and factors predictive of success. Br J Radiol. 2012;85:623–628. doi:10.1259/bjr/24538524. PMID: 21427184.
  • O'Neill MJ, Weissleder R, Gervais DA, Hahn PF, Mueller PR. Tunneled peritoneal catheter placement under sonographic and fluoroscopic guidance in the palliative treatment of malignant ascites. AJR Am J Roentgenol. 2001;177:615–618. doi:10.2214/ajr.177.3.1770615. PMID: 11517056.
  • Meier M, Mortensen FV, Madsen HH. Malignant ascites in patients with terminal cancer is effectively treated with permanent peritoneal catheter. Acta Radiol Open. 2015;4(7):2058460115579934. PMID: 26346641.
  • Reinglas J, Amjadi K, Petrcich B, Momoli F, Shaw-Stiffel T. The palliative management of refractory cirrhotic ascites using the PleurX© catheter. Can J Gastroenterol Hepatol. 2016;2016:4680543. PMID: 27446840.
  • Abdel-aal AK, Gaddikeri S, Saddekni S. Technique of peritoneal catheter placement under fluroscopic guidance. Radiol Res Pract. 2011;2011:141707. PMID: 22091373.
  • Stokes LS. Percutaneous management of malignant fluid collections. Semin Intervent Radiol. 2007;24:398–408. doi:10.1055/s-2007-992328. PMID: 21326592.
  • Bohn KA, Ray CE. Repeat large-volume paracentesis versus tunneled peritoneal catheter placement for malignant ascites: a cost-minimization study. AJR Am J Roentgenol. 2015;205:1126–1134. doi:10.2214/AJR.15.14484. PMID: 26496562.
  • Lee A, Lau TN, Yeong KY. Indwelling catheters for the management of malignant ascites. Support Care Cancer. 2000;8:493–499. PMID: 11094995.
  • Fleming ND, Alvarez-Secord A, von Gruenigen V, Miller MJ, Abernethy AP. Indwelling catheters for the management of refractory malignant ascites: a systematic literature overview and retrospective chart review. J Pain Symptom Manage. 2009;38:341–349. doi:10.1016/j.jpainsymman.2008.09.008. PMID: 19328648.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.